AFTER MORE THAN 40 YEARS OF TREATING non–muscle invasive bladder cancer (NMIBC), THE LANDSCAPE HAS EVOLVED YET THERE IS STILL A DESIRE TO DO MORE
It’s time to examine where we stand with NMIBC, which constitutes 75% of newly diagnosed bladder cancer cases.1

About Bladder Cancer

Long-Used Treatments

Patient Experiences with Long-Used Treatments
Reference:
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Bladder Cancer V7.2024. © National Comprehensive Cancer Network, Inc. 2025. All rights reserved. Accessed March 10, 2025. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.